Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharmaceutical R. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN110067006A reveals metal-free electrochemical route for antitumor indoles, offering green manufacturing and supply chain advantages for pharma intermediates.
Patent CN103649055B reveals high-yield pyrazole synthesis for DPP-IV inhibitors, offering cost reduction and scalable supply chain solutions for pharma manufacturers.
Patent CN112851674B reveals a novel rhodium-catalyzed double dehydrogenative coupling method for polysubstituted pyrroles, offering high efficiency and functional group diversity for industrial applications.
Patent CN1865234A reveals mild Wittig route for cis-capsaicin. Offers cost reduction and scalable supply for flavor and pharma industries.
Patent CN103333049A reveals a recyclable phosphotungstic acid ionic liquid catalyst for styrene oxide alcoholysis, offering high purity and reduced waste for pharmaceutical intermediate manufacturing.
Novel Cu-Ni catalytic method for high-purity pharmaceutical intermediates. Reduces cost and improves supply chain reliability for global buyers seeking stable production.
Discover the novel one-step preparation and resolution of 2-acylamino-3-biphenylpropionic acid. A cost-effective, high-purity route for API manufacturing.
Novel Ni-catalyzed desulfitative coupling of sulfonyl chlorides offers high yield and broad scope. A cost-effective route for API intermediates and fine chemicals.
Novel Pd-catalyzed C-H activation method ensures 99% ee. Reliable supplier for scalable chiral amine manufacturing with cost efficiency.
Novel catalytic hydrogenation route for Lenalidomide. High purity, reduced solvent use, scalable manufacturing for API intermediates.
Patent CN115403494B enables air-oxidized, metal-free synthesis of beta-hydroxy sulfones. Delivers high purity, cost efficiency, and scalable supply for pharmaceutical intermediates.
Novel Rh-catalyzed Zolpidem synthesis offers high purity and reduced toxic waste. Ideal for scalable pharmaceutical intermediate manufacturing and supply chain optimization.
Patent CN116354930A reveals a novel Pd/Cu catalyzed route for synthesizing chiral tetrahydroquinolines from amino acids, offering cost reduction and scalable manufacturing for pharmaceutical intermediates.
Patent CN106518663B reveals metal-free synthesis for alpha-acyloxy ketones. Offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN111777536A reveals a metal-free route to N-phenyl-3-(phenyldisulfanyl)propionamide using NFSI, offering significant cost reduction and supply chain reliability for pharma manufacturing.
Patent CN101935309A reveals a novel Ezetimibe synthesis using indeno-oxazole auxiliaries, offering 99.97% ee and scalable manufacturing for reliable API intermediate supply chains.
Novel visible light method reduces metal waste. Enhances supply chain stability for high-purity pharmaceutical intermediates. Cost-effective scalable production.
Novel palladium-catalyzed water-based method for asymmetric biphenyl. Reduces cost and environmental impact for pharmaceutical intermediate manufacturing.
Novel copper-catalyzed synthesis reduces costs and simplifies supply chains for high-purity pharmaceutical intermediates using mild conditions and efficient processes.
Patent CN115141184A reveals acid-catalyzed route boosting yield to 70%, offering cost reduction in pharmaceutical manufacturing and enhanced supply chain reliability.